Arrowhead Pharmaceuticals Reports 2024 Fiscal Year-End Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/14/2026
- Nasdaq ends sharply lower as hot inflation data stirs rate-hike worries
- Oil prices gain on attacks in Saudi Arabia, Iran's new tactics to target tankers
- U.S. consumer prices rise by 3.7% year-on-year in September
- Bank of America stock falls on earnings miss
- Netflix cuts 1,000 jobs as streaming giant seeks to boost engagement
| ARROWHEAD RESEARCH (NASDAQ: ARWR) | Delayed: 58.37 +0.24 (0.41%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $58.13 | 52 Week High | $8.22 | |||
| Open | $58.48 | 52 Week Low | $3.07 | |||
| Day High | $60.53 | P/E | N/A | |||
| Day Low | $57.15 | EPS | $-1.30 | |||
| Volume | 4,158,912 | |||||
